Oncoleader | Videos | The Future of CAR-T Cell Therapy for Cancer | The Foundation
Video Description
Release date: 2/22/2025
CAR-T cells have shown incredible clinical potential in certain hematological malignancies but the technology faces significant challenges that limits its use. Overcoming these hurdles to expand the use of CAR-T cells has the potential to revolutionize medicine. In this video I explore the history of CAR-T and lay out the 4 major hurdles that the technology faces today.
Course Instructor
Jeff Martin, PhD
Dr. Jeff Martin is a cancer biologist with a PhD in Cancer Genetics and over a decade of experience in immuno-oncology. As the Founder of Oncoleader, Jeff currently advises biotech professionals, providing expert insights on the best ways to navigate the current trends in the immuno-oncology industry.
